Publications

 


  • 18. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of Free/Total Prostate-Specific Analysis ratio, age-specific reference ranges, and PSA density.

    Bangma CH, Kranse R, Blijenberg BG, Schröder FH., 1995

    Journal: Urology
    Reference: 46(6):773-778.

    paper

  • 17. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

    Bangma CH, Kranse R, Blijenberg BG, Schröder FH., 1995

    Journal: Urology
    Reference: 46(6):773-778.

    paper

  • 16. Prostate-specific antigen: its clinical use and application in screening for prostate cancer.

    Bangma CH, Blijenberg BG, Schröder FH., 1995

    Journal: Scand J Clin Lab Invest.
    Reference: 55(suppl 221):35-44

  • 15. Screening, early detection, and treatment of prostate cancer: a European view.

    Schröder FH., 1995

    Journal: Urology
    Reference: 46(suppl 3a):62-70.

  • 14. Long-term survival and mortality in prostate cancer treated with non-curative intent.

    Aus G, Hugosson J, Norlen L., 1995

    Journal: The Journal of Urology
    Reference: 154:460-465.

    paper

  • 13. Impact of competing mortality on the cancer-related mortality in localized prostate cancer.

    Aus G, Pileblad E, Hugosson J., 1995

    Journal: Urology
    Reference: 46(5):672-675

    paper

  • 12. European randomized study of screening for prostate cancer: Progress report of Antwerp and Rotterdam pilot studies.

    Schröder FH, Denis LJ, Kirkels WJ, De Koning HJ, Standaert B., 1995

    Journal: Cancer
    Reference: 76(1):129-34.

    paper

  • 11. Report of the consensus workshop on screening and global strategy for prostate cancer.

    Denis LJ, Murphy GP, Schröder FH., 1995

    Journal: Cancer
    Reference: 75(5):1187-1207.

    paper

  • 10. Variabiliteit van uitslagen van prostaat specifiek antigeen met 6 bepalingsmethoden

    Bangma CH, Blijenberg BG, Schröder FH, 1994

    Journal: Ned Tijdschr Geneesk
    Reference: 138 (16) : 813-817

  • 9. De standaardisatie van de PSA-bepaling.

    Blijenberg BG., 1994

    Journal: Tijdschr Klin Chemie
    Reference: 19:271-274

  • 8. Parameters of prostate volume and shape in a community based population of men 55 to 74 years old.

    Bosch JLHR, Hop WCJ, Niemer AQHJ, Bangma CH, Kirkels WJ, Schröder FH., 1994

    Journal: The Journal of Urology
    Reference: 152:1501-5.

  • 7. The European screening study for prostate cancer.

    Schröder FH., 1994

    Journal: Canadian Journal of Oncology
    Reference: 4(suppl 1):102-5.

    paper

  • 6. Screening for prostate cancer (letter to the editor).

    Schröder FH., 1994

    Journal: The Lancet
    Reference: 343:1438-9.

  • 5. Screening for prostate cancer – necessity or nonsense?

    Schröder FH, Boyle P., 1993

    Journal: Eur J Cancer
    Reference: 29A(5):656-61.

    paper

  • 4. Prostate cancer: to screen or not to screen?

    Schröder FH, 1993

    Journal: BMJ
    Reference: 306:407-8.

    paper

  • 3. Evaluatie van de vroege opsporing van prostaatkanker.

    Nijs HGT, Tordoir DMR, Schuurman JH, Kirkels WJ, Schröder FH., 1993

    Journal: Tijdschr Soc Gezondheidszorg
    Reference: 78:31A.

  • 2. Vasectomie en prostaatkanker; toelichting en praktische adviezen.

    Schröder FH, Damhuis RAM., 1993

    Journal: Ned Tijdschr Geneeskd
    Reference: 137(10):485-6.

  • 1. Modalities available for screening for prostate cancer.

    Bentvelsen FM, Schröder FH., 1993

    Journal: Eur J Cancer
    Reference: 29A(6):804-11.

← Previous